# Clinical on the Safety and Efficacy of Fosaprepitant Dimeglumine for Injection in the Prevention of CINV.

> **NCT05755659** · NA · UNKNOWN · sponsor: **Xijing Hospital** · enrollment: 3000 (estimated)

## Conditions studied

- Neoplasms

## Interventions

- **DRUG:** Fosaprepitant Dimeglumine for Injection

## Key facts

- **NCT ID:** NCT05755659
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-07-15
- **Primary completion:** 2024-10-20
- **Final completion:** 2024-12-20
- **Target enrollment:** 3000 (ESTIMATED)
- **Last updated:** 2023-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05755659

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05755659, "Clinical on the Safety and Efficacy of Fosaprepitant Dimeglumine for Injection in the Prevention of CINV.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05755659. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*